Further subgroup analyses showed that the positive association between S100A12 and the risk of PAD was significant in all subgroups, regardless of whether HDL-C levels were less than 1.03 mmol/L, age greater than 60 years, and presence of diabetes or hypertension. Here, S100A12 is linked to hypertensive disorder.